Detalles de la búsqueda
1.
New approach to implement cancer patient care: The valutazione percorso rete oncologica campana (ValPeROC)-experience from an Italian oncology network.
Eur J Cancer Care (Engl)
; 31(6): e13736, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37039607
2.
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
BMC Cancer
; 19(1): 899, 2019 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31500586
3.
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy.
Oncology
; 90(1): 36-42, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26731722
4.
Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report.
Front Oncol
; 13: 1084681, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36814823
5.
Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome.
J Transl Med
; 10: 232, 2012 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23171437
6.
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies.
Cancers (Basel)
; 14(4)2022 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35205799
7.
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA Netw Open
; 4(7): e2118475, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34309665
8.
Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting.
PLoS One
; 15(11): e0241431, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33211702
9.
Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis.
Cancers (Basel)
; 12(7)2020 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32708575
10.
Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial.
Clin Colorectal Cancer
; 19(4): 270-276, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32631788
11.
Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?
Front Oncol
; 8: 62, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29594042
12.
Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives.
Curr Cancer Drug Targets
; 18(5): 421-429, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-28183254
13.
First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.
Front Pharmacol
; 9: 441, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29773991
14.
Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors.
Oncotarget
; 9(81): 35251-35265, 2018 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30443292
15.
[Late complete response after long remission from treatment with FOLFIRI-aflibercept for metastatic colorectal cancer after progression to FOLFOX-bevacizumab]. / Tardiva risposta completa dopo lunga remissione da trattamento con schedula FOLFIRI-aflibercept per cancro colorettale metastatico dopo progressione a schedula folfox-bevacizumab.
Recenti Prog Med
; 106(8): e407-13, 2015 Aug.
Artículo
en Italiano
| MEDLINE | ID: mdl-26228865
16.
FOLFOXIRI in metastatic colorectal cancer: A criticism from its native land.
Cancer Lett
; 408: 71-72, 2017 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28844712
Resultados
1 -
16
de 16
1
Próxima >
>>